| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patient Safety | 22 | 2019 | 244 | 5.690 |
Why?
|
| Quality Improvement | 16 | 2020 | 428 | 4.060 |
Why?
|
| Medical Errors | 13 | 2023 | 193 | 4.000 |
Why?
|
| Academic Medical Centers | 14 | 2020 | 314 | 3.170 |
Why?
|
| Clinical Alarms | 5 | 2021 | 12 | 3.140 |
Why?
|
| Blood Transfusion | 5 | 2023 | 150 | 2.900 |
Why?
|
| Safety Management | 10 | 2017 | 143 | 2.730 |
Why?
|
| Thoracic Surgery | 8 | 2021 | 68 | 2.410 |
Why?
|
| Cardiac Surgical Procedures | 8 | 2023 | 249 | 2.340 |
Why?
|
| Pneumonectomy | 14 | 2024 | 84 | 2.260 |
Why?
|
| Thoracic Surgical Procedures | 7 | 2020 | 33 | 2.130 |
Why?
|
| Surgeons | 7 | 2020 | 157 | 2.090 |
Why?
|
| Lung Neoplasms | 15 | 2024 | 577 | 1.970 |
Why?
|
| Organizational Culture | 6 | 2018 | 111 | 1.930 |
Why?
|
| Lung Transplantation | 7 | 2015 | 48 | 1.850 |
Why?
|
| Operating Rooms | 6 | 2021 | 53 | 1.800 |
Why?
|
| Humans | 132 | 2024 | 60049 | 1.770 |
Why?
|
| Quality Indicators, Health Care | 7 | 2017 | 331 | 1.740 |
Why?
|
| Checklist | 4 | 2017 | 75 | 1.470 |
Why?
|
| Hospitals | 5 | 2021 | 376 | 1.440 |
Why?
|
| Heart Diseases | 3 | 2017 | 206 | 1.340 |
Why?
|
| Internship and Residency | 6 | 2023 | 746 | 1.330 |
Why?
|
| Robotic Surgical Procedures | 9 | 2024 | 108 | 1.300 |
Why?
|
| Monitoring, Physiologic | 5 | 2021 | 150 | 1.300 |
Why?
|
| Societies, Medical | 2 | 2021 | 341 | 1.270 |
Why?
|
| Inservice Training | 4 | 2016 | 85 | 1.250 |
Why?
|
| Education, Medical, Graduate | 4 | 2023 | 319 | 1.250 |
Why?
|
| Practice Guidelines as Topic | 8 | 2021 | 712 | 1.250 |
Why?
|
| Physicians | 5 | 2019 | 441 | 1.240 |
Why?
|
| Patient Transfer | 4 | 2019 | 91 | 1.210 |
Why?
|
| Patient Satisfaction | 4 | 2020 | 418 | 1.170 |
Why?
|
| Quality of Health Care | 3 | 2017 | 524 | 1.150 |
Why?
|
| Quality Assurance, Health Care | 3 | 2016 | 248 | 1.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 8 | 2024 | 147 | 1.090 |
Why?
|
| Emergency Service, Hospital | 6 | 2019 | 1037 | 1.070 |
Why?
|
| Specialties, Surgical | 3 | 2018 | 45 | 1.050 |
Why?
|
| Foreign Bodies | 4 | 2014 | 46 | 1.020 |
Why?
|
| Delivery of Health Care | 4 | 2020 | 424 | 1.010 |
Why?
|
| Truth Disclosure | 3 | 2019 | 54 | 1.010 |
Why?
|
| Retrospective Studies | 32 | 2024 | 6125 | 0.990 |
Why?
|
| Autistic Disorder | 6 | 2022 | 169 | 0.940 |
Why?
|
| Health Personnel | 3 | 2019 | 343 | 0.940 |
Why?
|
| Lung Diseases | 2 | 2015 | 166 | 0.900 |
Why?
|
| Sound | 2 | 2021 | 11 | 0.860 |
Why?
|
| Ohio | 10 | 2020 | 26 | 0.850 |
Why?
|
| Curriculum | 4 | 2023 | 569 | 0.850 |
Why?
|
| Thoracic Surgery, Video-Assisted | 6 | 2024 | 56 | 0.790 |
Why?
|
| Male | 52 | 2024 | 27914 | 0.780 |
Why?
|
| Patient Care Team | 6 | 2019 | 334 | 0.770 |
Why?
|
| Surgical Procedures, Operative | 4 | 2020 | 139 | 0.770 |
Why?
|
| Inpatients | 5 | 2022 | 300 | 0.770 |
Why?
|
| Bloodless Medical and Surgical Procedures | 1 | 2021 | 1 | 0.760 |
Why?
|
| Leadership | 4 | 2018 | 200 | 0.760 |
Why?
|
| Communication | 5 | 2019 | 556 | 0.740 |
Why?
|
| Middle Aged | 34 | 2024 | 16500 | 0.740 |
Why?
|
| Length of Stay | 11 | 2024 | 779 | 0.740 |
Why?
|
| Benchmarking | 2 | 2019 | 138 | 0.740 |
Why?
|
| Treatment Outcome | 14 | 2024 | 5258 | 0.730 |
Why?
|
| Social Media | 3 | 2019 | 112 | 0.720 |
Why?
|
| Female | 48 | 2024 | 31191 | 0.710 |
Why?
|
| Bone Marrow Cells | 2 | 2019 | 232 | 0.700 |
Why?
|
| Unsupervised Machine Learning | 1 | 2020 | 2 | 0.700 |
Why?
|
| Patient Portals | 4 | 2022 | 47 | 0.700 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2012 | 153 | 0.700 |
Why?
|
| Anatomy | 2 | 2011 | 16 | 0.700 |
Why?
|
| Intergenerational Relations | 1 | 2020 | 6 | 0.700 |
Why?
|
| Burnout, Professional | 2 | 2019 | 125 | 0.690 |
Why?
|
| Meaningful Use | 1 | 2019 | 8 | 0.670 |
Why?
|
| Acoustics | 1 | 2019 | 10 | 0.670 |
Why?
|
| Mentors | 1 | 2020 | 119 | 0.670 |
Why?
|
| Biomedical Research | 2 | 2020 | 251 | 0.670 |
Why?
|
| Documentation | 2 | 2018 | 129 | 0.670 |
Why?
|
| Colorectal Surgery | 1 | 2020 | 52 | 0.670 |
Why?
|
| Auditory Perception | 1 | 2019 | 33 | 0.660 |
Why?
|
| Attitude of Health Personnel | 6 | 2019 | 564 | 0.660 |
Why?
|
| United States | 20 | 2022 | 7593 | 0.650 |
Why?
|
| Electronic Health Records | 5 | 2022 | 354 | 0.640 |
Why?
|
| Intraoperative Period | 2 | 2020 | 34 | 0.640 |
Why?
|
| Emergencies | 1 | 2019 | 114 | 0.640 |
Why?
|
| Medical Informatics | 2 | 2018 | 68 | 0.640 |
Why?
|
| Time Factors | 13 | 2024 | 3610 | 0.630 |
Why?
|
| Resilience, Psychological | 1 | 2019 | 57 | 0.620 |
Why?
|
| Mindfulness | 1 | 2019 | 64 | 0.620 |
Why?
|
| Coronary Artery Bypass | 3 | 2018 | 274 | 0.610 |
Why?
|
| Machine Learning | 1 | 2020 | 151 | 0.610 |
Why?
|
| Iatrogenic Disease | 2 | 2019 | 58 | 0.610 |
Why?
|
| Registries | 2 | 2020 | 805 | 0.610 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 125 | 0.610 |
Why?
|
| Immunosuppressive Agents | 3 | 2009 | 303 | 0.610 |
Why?
|
| Aged | 27 | 2024 | 13553 | 0.610 |
Why?
|
| Surgical Instruments | 3 | 2014 | 41 | 0.610 |
Why?
|
| Patient Readmission | 3 | 2018 | 424 | 0.600 |
Why?
|
| Postoperative Complications | 8 | 2019 | 1169 | 0.600 |
Why?
|
| Pulmonary Emphysema | 1 | 2018 | 87 | 0.590 |
Why?
|
| Esophageal Diseases | 1 | 2017 | 16 | 0.580 |
Why?
|
| Professional Competence | 1 | 2018 | 89 | 0.580 |
Why?
|
| Respiratory Tract Diseases | 1 | 2017 | 35 | 0.580 |
Why?
|
| Lymph Nodes | 4 | 2022 | 213 | 0.570 |
Why?
|
| Accidental Falls | 2 | 2016 | 148 | 0.560 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2022 | 453 | 0.560 |
Why?
|
| Health Services Research | 2 | 2018 | 270 | 0.560 |
Why?
|
| Cooperative Behavior | 2 | 2018 | 220 | 0.560 |
Why?
|
| Health Services Needs and Demand | 2 | 2018 | 215 | 0.550 |
Why?
|
| Public Opinion | 1 | 2017 | 22 | 0.550 |
Why?
|
| Workflow | 1 | 2017 | 63 | 0.550 |
Why?
|
| Intraoperative Complications | 3 | 2017 | 83 | 0.550 |
Why?
|
| Efficiency, Organizational | 1 | 2017 | 95 | 0.540 |
Why?
|
| Crisis Intervention | 1 | 2017 | 29 | 0.540 |
Why?
|
| Interprofessional Relations | 3 | 2016 | 133 | 0.540 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 213 | 0.540 |
Why?
|
| Needs Assessment | 1 | 2017 | 192 | 0.530 |
Why?
|
| Family | 2 | 2022 | 224 | 0.530 |
Why?
|
| Shame | 1 | 2016 | 8 | 0.530 |
Why?
|
| Research Report | 1 | 2016 | 28 | 0.510 |
Why?
|
| Venous Thromboembolism | 1 | 2017 | 142 | 0.510 |
Why?
|
| Medication Errors | 2 | 2013 | 116 | 0.500 |
Why?
|
| Practice Management, Medical | 1 | 2015 | 20 | 0.500 |
Why?
|
| Marketing of Health Services | 1 | 2015 | 23 | 0.500 |
Why?
|
| Risk Management | 1 | 2016 | 39 | 0.500 |
Why?
|
| Fatigue | 1 | 2016 | 104 | 0.500 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 457 | 0.490 |
Why?
|
| Global Health | 3 | 2021 | 164 | 0.490 |
Why?
|
| American Heart Association | 1 | 2016 | 128 | 0.490 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2020 | 676 | 0.480 |
Why?
|
| Clostridium Infections | 3 | 2020 | 47 | 0.470 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2012 | 197 | 0.470 |
Why?
|
| Public Health | 1 | 2016 | 180 | 0.460 |
Why?
|
| Anxiety | 2 | 2022 | 400 | 0.460 |
Why?
|
| United States Agency for Healthcare Research and Quality | 4 | 2017 | 30 | 0.460 |
Why?
|
| Adenocarcinoma | 2 | 2022 | 327 | 0.450 |
Why?
|
| Cardiology | 1 | 2016 | 163 | 0.450 |
Why?
|
| Autism Spectrum Disorder | 3 | 2022 | 181 | 0.450 |
Why?
|
| Physician-Patient Relations | 2 | 2019 | 392 | 0.440 |
Why?
|
| Adult | 22 | 2024 | 15949 | 0.440 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 267 | 0.440 |
Why?
|
| Narration | 1 | 2014 | 44 | 0.440 |
Why?
|
| Patient Handoff | 1 | 2014 | 37 | 0.440 |
Why?
|
| Certification | 1 | 2014 | 49 | 0.440 |
Why?
|
| Respiration, Artificial | 1 | 2016 | 296 | 0.430 |
Why?
|
| Integrin alpha Chains | 2 | 2010 | 10 | 0.430 |
Why?
|
| Students, Medical | 3 | 2012 | 246 | 0.430 |
Why?
|
| Mediastinum | 3 | 2019 | 25 | 0.430 |
Why?
|
| Advisory Committees | 1 | 2014 | 107 | 0.420 |
Why?
|
| Organ Transplantation | 1 | 2013 | 51 | 0.410 |
Why?
|
| Wounds and Injuries | 1 | 2015 | 243 | 0.410 |
Why?
|
| Risk Factors | 13 | 2018 | 5068 | 0.410 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 543 | 0.410 |
Why?
|
| Biopsy, Needle | 2 | 2010 | 129 | 0.410 |
Why?
|
| Photochemotherapy | 1 | 2012 | 20 | 0.410 |
Why?
|
| Antigens, CD | 3 | 2011 | 343 | 0.410 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2010 | 170 | 0.400 |
Why?
|
| Thoracotomy | 3 | 2019 | 46 | 0.400 |
Why?
|
| Gynecology | 1 | 2012 | 54 | 0.400 |
Why?
|
| Hospital Mortality | 4 | 2018 | 851 | 0.390 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2012 | 165 | 0.390 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2012 | 56 | 0.390 |
Why?
|
| Root Cause Analysis | 1 | 2011 | 2 | 0.380 |
Why?
|
| Catheterization | 1 | 2012 | 111 | 0.380 |
Why?
|
| Preoperative Care | 3 | 2020 | 177 | 0.380 |
Why?
|
| Algorithms | 1 | 2017 | 1001 | 0.380 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 736 | 0.380 |
Why?
|
| Robotics | 1 | 2012 | 54 | 0.380 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 107 | 0.380 |
Why?
|
| Obstetrics | 1 | 2012 | 87 | 0.370 |
Why?
|
| Workload | 3 | 2017 | 122 | 0.360 |
Why?
|
| Mediastinal Diseases | 1 | 2010 | 13 | 0.350 |
Why?
|
| Risk Assessment | 7 | 2018 | 1933 | 0.350 |
Why?
|
| Equipment Failure | 3 | 2016 | 65 | 0.350 |
Why?
|
| Endosonography | 1 | 2010 | 33 | 0.340 |
Why?
|
| Bronchiolitis Obliterans | 2 | 2010 | 17 | 0.340 |
Why?
|
| Anticoagulants | 3 | 2023 | 487 | 0.340 |
Why?
|
| Ergonomics | 2 | 2021 | 77 | 0.340 |
Why?
|
| Transplantation Tolerance | 1 | 2010 | 65 | 0.340 |
Why?
|
| Extravascular Lung Water | 1 | 2009 | 3 | 0.340 |
Why?
|
| Phentolamine | 1 | 2009 | 7 | 0.340 |
Why?
|
| Cross Infection | 3 | 2020 | 154 | 0.340 |
Why?
|
| Orthopedic Procedures | 2 | 2021 | 45 | 0.330 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2009 | 14 | 0.330 |
Why?
|
| Tacrolimus | 1 | 2009 | 39 | 0.330 |
Why?
|
| Follow-Up Studies | 7 | 2020 | 2361 | 0.330 |
Why?
|
| Pulmonary Alveoli | 1 | 2009 | 44 | 0.330 |
Why?
|
| Abscess | 1 | 2010 | 75 | 0.330 |
Why?
|
| Pulmonary Edema | 1 | 2009 | 25 | 0.330 |
Why?
|
| Mental Disorders | 1 | 2017 | 768 | 0.330 |
Why?
|
| Ultrasonography, Interventional | 1 | 2010 | 92 | 0.330 |
Why?
|
| Health Resources | 2 | 2020 | 88 | 0.320 |
Why?
|
| Feasibility Studies | 3 | 2019 | 531 | 0.310 |
Why?
|
| Cohort Studies | 6 | 2020 | 2479 | 0.310 |
Why?
|
| Patient Acuity | 2 | 2018 | 18 | 0.310 |
Why?
|
| Teaching | 1 | 2009 | 157 | 0.310 |
Why?
|
| Hyperammonemia | 1 | 2008 | 4 | 0.310 |
Why?
|
| Ammonia | 1 | 2008 | 15 | 0.300 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2008 | 80 | 0.300 |
Why?
|
| Organizational Innovation | 3 | 2019 | 84 | 0.300 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 2019 | 43 | 0.300 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2010 | 239 | 0.300 |
Why?
|
| Reaction Time | 2 | 2021 | 119 | 0.300 |
Why?
|
| Bioprosthesis | 2 | 2007 | 39 | 0.290 |
Why?
|
| Positron-Emission Tomography | 1 | 2008 | 174 | 0.290 |
Why?
|
| Patient Education as Topic | 2 | 2024 | 448 | 0.290 |
Why?
|
| Education, Medical | 1 | 2009 | 178 | 0.290 |
Why?
|
| Lymphatic Metastasis | 2 | 2019 | 70 | 0.280 |
Why?
|
| General Surgery | 1 | 2009 | 193 | 0.280 |
Why?
|
| Telemedicine | 2 | 2022 | 336 | 0.270 |
Why?
|
| Total Quality Management | 2 | 2016 | 57 | 0.270 |
Why?
|
| Value-Based Purchasing | 2 | 2017 | 8 | 0.270 |
Why?
|
| Antibodies, Monoclonal | 2 | 2010 | 857 | 0.260 |
Why?
|
| Heart-Lung Transplantation | 1 | 2006 | 4 | 0.260 |
Why?
|
| Nurses | 2 | 2018 | 104 | 0.260 |
Why?
|
| Neoplasm Staging | 5 | 2024 | 458 | 0.250 |
Why?
|
| Survival Rate | 4 | 2020 | 793 | 0.250 |
Why?
|
| Endovascular Procedures | 1 | 2012 | 576 | 0.250 |
Why?
|
| Nursing Staff, Hospital | 2 | 2017 | 73 | 0.250 |
Why?
|
| Primary Health Care | 5 | 2022 | 660 | 0.240 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 5181 | 0.240 |
Why?
|
| Graft Rejection | 3 | 2010 | 259 | 0.240 |
Why?
|
| Patient Participation | 4 | 2022 | 212 | 0.240 |
Why?
|
| Mitral Valve Stenosis | 1 | 2004 | 11 | 0.240 |
Why?
|
| Young Adult | 6 | 2024 | 4384 | 0.230 |
Why?
|
| Pneumothorax | 1 | 2024 | 45 | 0.230 |
Why?
|
| Pressure Ulcer | 2 | 2014 | 37 | 0.230 |
Why?
|
| Clinical Competence | 2 | 2023 | 698 | 0.220 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2004 | 75 | 0.220 |
Why?
|
| Postoperative Period | 2 | 2020 | 126 | 0.220 |
Why?
|
| Esophagectomy | 1 | 2024 | 47 | 0.210 |
Why?
|
| Heart Valve Prosthesis | 1 | 2004 | 90 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2019 | 1480 | 0.210 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 80 | 0.210 |
Why?
|
| Competency-Based Education | 1 | 2023 | 29 | 0.210 |
Why?
|
| Professionalism | 2 | 2019 | 10 | 0.200 |
Why?
|
| Midwestern United States | 3 | 2017 | 24 | 0.200 |
Why?
|
| Canada | 1 | 2023 | 150 | 0.200 |
Why?
|
| Lymphadenopathy | 1 | 2022 | 23 | 0.200 |
Why?
|
| Mutation | 1 | 2010 | 2464 | 0.200 |
Why?
|
| Nursing Staff | 1 | 2022 | 41 | 0.190 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 173 | 0.190 |
Why?
|
| Financial Management | 1 | 2021 | 6 | 0.190 |
Why?
|
| Medical Audit | 2 | 2012 | 60 | 0.190 |
Why?
|
| Perioperative Period | 1 | 2021 | 20 | 0.190 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 2 | 2011 | 11 | 0.190 |
Why?
|
| Respiratory Function Tests | 2 | 2018 | 165 | 0.190 |
Why?
|
| Surgical Wound Infection | 2 | 2021 | 110 | 0.190 |
Why?
|
| Telemetry | 1 | 2021 | 21 | 0.190 |
Why?
|
| Hospital Costs | 2 | 2019 | 120 | 0.190 |
Why?
|
| Anesthesiology | 1 | 2021 | 42 | 0.180 |
Why?
|
| Operative Time | 5 | 2019 | 68 | 0.180 |
Why?
|
| Educational Measurement | 2 | 2014 | 213 | 0.180 |
Why?
|
| Body Mass Index | 3 | 2014 | 892 | 0.180 |
Why?
|
| Diet, Carbohydrate Loading | 1 | 2020 | 2 | 0.180 |
Why?
|
| Inflammation | 4 | 2011 | 1109 | 0.180 |
Why?
|
| Perception | 2 | 2020 | 179 | 0.180 |
Why?
|
| Patient-Centered Care | 2 | 2020 | 249 | 0.180 |
Why?
|
| Subacute Care | 1 | 2020 | 9 | 0.180 |
Why?
|
| Qualitative Research | 3 | 2022 | 629 | 0.180 |
Why?
|
| Forecasting | 2 | 2020 | 221 | 0.180 |
Why?
|
| Surveys and Questionnaires | 4 | 2024 | 2611 | 0.180 |
Why?
|
| Anesthesiologists | 2 | 2021 | 17 | 0.180 |
Why?
|
| Adolescent | 4 | 2020 | 5949 | 0.180 |
Why?
|
| Tracheal Neoplasms | 1 | 2020 | 3 | 0.180 |
Why?
|
| Health Expenditures | 1 | 2022 | 118 | 0.180 |
Why?
|
| Plagiarism | 1 | 2020 | 4 | 0.170 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 1471 | 0.170 |
Why?
|
| Scientific Misconduct | 1 | 2020 | 11 | 0.170 |
Why?
|
| Patient Discharge | 2 | 2022 | 483 | 0.170 |
Why?
|
| Anemia | 1 | 2021 | 119 | 0.170 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 107 | 0.170 |
Why?
|
| Codes of Ethics | 1 | 2019 | 3 | 0.170 |
Why?
|
| Thymectomy | 1 | 2019 | 34 | 0.170 |
Why?
|
| Adaptation, Physiological | 1 | 2000 | 118 | 0.170 |
Why?
|
| Obesity | 3 | 2014 | 1190 | 0.160 |
Why?
|
| Bronchial Fistula | 1 | 2019 | 4 | 0.160 |
Why?
|
| Personnel, Hospital | 1 | 2019 | 39 | 0.160 |
Why?
|
| Cluster Analysis | 1 | 2020 | 252 | 0.160 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2021 | 216 | 0.160 |
Why?
|
| Learning Curve | 1 | 2019 | 27 | 0.160 |
Why?
|
| Empyema | 1 | 2019 | 5 | 0.160 |
Why?
|
| Pleural Diseases | 1 | 2019 | 9 | 0.160 |
Why?
|
| Sarcopenia | 1 | 2019 | 21 | 0.160 |
Why?
|
| Tissue Adhesions | 1 | 2019 | 20 | 0.160 |
Why?
|
| Ethics, Medical | 1 | 2019 | 38 | 0.160 |
Why?
|
| Empathy | 1 | 2019 | 65 | 0.160 |
Why?
|
| Trans-Activators | 1 | 2000 | 295 | 0.160 |
Why?
|
| Hospitals, University | 1 | 2018 | 51 | 0.160 |
Why?
|
| Diskectomy | 1 | 2019 | 29 | 0.150 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2018 | 11 | 0.150 |
Why?
|
| Equipment Design | 1 | 2019 | 319 | 0.150 |
Why?
|
| Age Factors | 2 | 2017 | 1524 | 0.150 |
Why?
|
| Critical Care | 2 | 2020 | 417 | 0.150 |
Why?
|
| Controlled Before-After Studies | 2 | 2019 | 6 | 0.150 |
Why?
|
| Confidence Intervals | 1 | 2018 | 257 | 0.150 |
Why?
|
| Mice | 10 | 2012 | 10311 | 0.150 |
Why?
|
| Population Dynamics | 1 | 2017 | 18 | 0.150 |
Why?
|
| Colectomy | 1 | 2018 | 99 | 0.150 |
Why?
|
| Blood Glucose | 1 | 2020 | 473 | 0.150 |
Why?
|
| Cervical Vertebrae | 1 | 2019 | 102 | 0.150 |
Why?
|
| Caregivers | 1 | 2020 | 232 | 0.150 |
Why?
|
| Professional-Patient Relations | 2 | 2019 | 128 | 0.140 |
Why?
|
| Respiratory Insufficiency | 2 | 2018 | 155 | 0.140 |
Why?
|
| Personnel Administration, Hospital | 1 | 2017 | 1 | 0.140 |
Why?
|
| Job Satisfaction | 1 | 2018 | 132 | 0.140 |
Why?
|
| Computer User Training | 1 | 2017 | 7 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 391 | 0.140 |
Why?
|
| Malpractice | 1 | 2017 | 17 | 0.140 |
Why?
|
| Postoperative Care | 2 | 2008 | 114 | 0.140 |
Why?
|
| Cholesterol | 1 | 2018 | 255 | 0.140 |
Why?
|
| Spinal Fusion | 1 | 2019 | 127 | 0.140 |
Why?
|
| Self Efficacy | 1 | 2018 | 199 | 0.140 |
Why?
|
| Suicidal Ideation | 1 | 2018 | 114 | 0.140 |
Why?
|
| Attention | 2 | 2016 | 151 | 0.140 |
Why?
|
| Perioperative Care | 1 | 2017 | 79 | 0.140 |
Why?
|
| Formative Feedback | 1 | 2016 | 8 | 0.140 |
Why?
|
| Airway Extubation | 1 | 2016 | 5 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 332 | 0.140 |
Why?
|
| Logistic Models | 2 | 2018 | 1255 | 0.140 |
Why?
|
| Models, Econometric | 1 | 2016 | 14 | 0.130 |
Why?
|
| Animals | 11 | 2012 | 19729 | 0.130 |
Why?
|
| Lung | 2 | 2019 | 841 | 0.130 |
Why?
|
| User-Computer Interface | 1 | 2017 | 131 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 3 | 2010 | 880 | 0.130 |
Why?
|
| Choice Behavior | 1 | 2017 | 77 | 0.130 |
Why?
|
| Costs and Cost Analysis | 1 | 2016 | 100 | 0.130 |
Why?
|
| Muscle, Skeletal | 2 | 2019 | 678 | 0.130 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 82 | 0.130 |
Why?
|
| Social Support | 1 | 2018 | 363 | 0.120 |
Why?
|
| Clinical Protocols | 1 | 2016 | 137 | 0.120 |
Why?
|
| Models, Biological | 1 | 2000 | 1141 | 0.120 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 1565 | 0.120 |
Why?
|
| Health Priorities | 1 | 2014 | 22 | 0.120 |
Why?
|
| Hospital Administration | 1 | 2014 | 41 | 0.120 |
Why?
|
| Endothelium, Vascular | 3 | 2011 | 171 | 0.110 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2014 | 46 | 0.110 |
Why?
|
| Uracil | 2 | 2011 | 31 | 0.110 |
Why?
|
| Piperidines | 2 | 2011 | 50 | 0.110 |
Why?
|
| Pneumonia | 2 | 2008 | 272 | 0.110 |
Why?
|
| Interviews as Topic | 1 | 2016 | 494 | 0.110 |
Why?
|
| Medication Systems, Hospital | 1 | 2013 | 10 | 0.110 |
Why?
|
| Software | 1 | 2017 | 373 | 0.110 |
Why?
|
| Intra-Abdominal Fat | 2 | 2011 | 34 | 0.110 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2014 | 72 | 0.110 |
Why?
|
| Incidence | 4 | 2014 | 1255 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 3 | 2019 | 303 | 0.110 |
Why?
|
| Intensive Care Units | 2 | 2014 | 454 | 0.110 |
Why?
|
| Biopsy | 1 | 2014 | 376 | 0.100 |
Why?
|
| Transplantation, Homologous | 2 | 2010 | 234 | 0.100 |
Why?
|
| Faculty, Medical | 2 | 2018 | 203 | 0.100 |
Why?
|
| Consumer Health Information | 1 | 2013 | 35 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 5 | 2011 | 3207 | 0.100 |
Why?
|
| Educational Status | 1 | 2014 | 273 | 0.100 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2018 | 50 | 0.100 |
Why?
|
| Medicare | 3 | 2022 | 602 | 0.100 |
Why?
|
| Th17 Cells | 1 | 2012 | 56 | 0.100 |
Why?
|
| Interleukin-4 | 1 | 2012 | 141 | 0.100 |
Why?
|
| Luminescent Proteins | 2 | 2009 | 129 | 0.100 |
Why?
|
| Interleukin-12 | 1 | 2012 | 123 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2009 | 2891 | 0.100 |
Why?
|
| Prevalence | 3 | 2022 | 1292 | 0.100 |
Why?
|
| Health Care Reform | 1 | 2012 | 88 | 0.100 |
Why?
|
| Physician's Role | 1 | 2013 | 120 | 0.100 |
Why?
|
| Chemotaxis | 1 | 2011 | 47 | 0.100 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2011 | 7 | 0.090 |
Why?
|
| Depression | 1 | 2018 | 868 | 0.090 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2011 | 23 | 0.090 |
Why?
|
| NADPH Oxidases | 1 | 2011 | 64 | 0.090 |
Why?
|
| Case-Control Studies | 4 | 2019 | 1063 | 0.090 |
Why?
|
| DNA Fingerprinting | 1 | 2010 | 7 | 0.090 |
Why?
|
| Prognosis | 3 | 2020 | 1589 | 0.090 |
Why?
|
| Particulate Matter | 1 | 2011 | 59 | 0.090 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2010 | 29 | 0.090 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2010 | 3 | 0.090 |
Why?
|
| Aorta | 1 | 2011 | 106 | 0.090 |
Why?
|
| Multivariate Analysis | 3 | 2019 | 928 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2012 | 487 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2011 | 72 | 0.090 |
Why?
|
| Cognition | 1 | 2014 | 466 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2011 | 148 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 60 | 0.080 |
Why?
|
| Career Choice | 1 | 2011 | 113 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 1035 | 0.080 |
Why?
|
| Attitude to Computers | 2 | 2019 | 21 | 0.080 |
Why?
|
| Lymphocyte Subsets | 1 | 2009 | 35 | 0.080 |
Why?
|
| Monocytes | 1 | 2011 | 344 | 0.080 |
Why?
|
| Decision Making | 1 | 2013 | 394 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2009 | 51 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2011 | 348 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2011 | 298 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2010 | 364 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 153 | 0.080 |
Why?
|
| Gamma Cameras | 1 | 2008 | 6 | 0.080 |
Why?
|
| Sex Factors | 2 | 2018 | 969 | 0.080 |
Why?
|
| Whole Body Imaging | 1 | 2008 | 10 | 0.080 |
Why?
|
| Air Pollution | 1 | 2009 | 34 | 0.080 |
Why?
|
| Models, Animal | 1 | 2009 | 221 | 0.080 |
Why?
|
| Purines | 1 | 2008 | 38 | 0.080 |
Why?
|
| Acinetobacter Infections | 1 | 2008 | 6 | 0.080 |
Why?
|
| Graft Survival | 1 | 2009 | 279 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 278 | 0.080 |
Why?
|
| Databases, Factual | 2 | 2024 | 849 | 0.080 |
Why?
|
| Dogs | 1 | 2009 | 306 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2009 | 176 | 0.070 |
Why?
|
| Neoplasms | 1 | 2018 | 1260 | 0.070 |
Why?
|
| Islets of Langerhans | 1 | 2009 | 267 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 910 | 0.070 |
Why?
|
| Environmental Exposure | 3 | 2018 | 206 | 0.070 |
Why?
|
| Linear Models | 2 | 2018 | 422 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2008 | 282 | 0.070 |
Why?
|
| Thromboembolism | 1 | 2007 | 70 | 0.070 |
Why?
|
| Anti-Infective Agents | 1 | 2008 | 140 | 0.070 |
Why?
|
| Phenotype | 1 | 2010 | 1157 | 0.070 |
Why?
|
| Heart Valve Diseases | 1 | 2007 | 88 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 1100 | 0.060 |
Why?
|
| Cytomegalovirus Infections | 1 | 2006 | 70 | 0.060 |
Why?
|
| Aortic Valve | 1 | 2007 | 170 | 0.060 |
Why?
|
| Pleura | 1 | 2024 | 12 | 0.060 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2007 | 155 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2006 | 557 | 0.060 |
Why?
|
| Prosthesis Failure | 1 | 2004 | 71 | 0.060 |
Why?
|
| Acute Disease | 1 | 2006 | 661 | 0.060 |
Why?
|
| Echocardiography, Doppler | 1 | 2004 | 131 | 0.060 |
Why?
|
| Prosthesis Design | 1 | 2004 | 209 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2024 | 93 | 0.050 |
Why?
|
| Factor Xa | 1 | 2023 | 6 | 0.050 |
Why?
|
| Rivaroxaban | 1 | 2023 | 22 | 0.050 |
Why?
|
| Insulin Resistance | 3 | 2011 | 407 | 0.050 |
Why?
|
| Factor Xa Inhibitors | 1 | 2023 | 36 | 0.050 |
Why?
|
| Blood Coagulation | 1 | 2023 | 39 | 0.050 |
Why?
|
| Recurrence | 1 | 2024 | 599 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 2491 | 0.050 |
Why?
|
| Aftercare | 1 | 2022 | 67 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2021 | 3126 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2011 | 1225 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2024 | 930 | 0.050 |
Why?
|
| Mice, Inbred CBA | 1 | 2000 | 82 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2023 | 696 | 0.040 |
Why?
|
| Heart Failure | 1 | 2008 | 869 | 0.040 |
Why?
|
| Preventive Health Services | 1 | 2021 | 72 | 0.040 |
Why?
|
| Geographic Mapping | 1 | 2019 | 6 | 0.040 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 14 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 158 | 0.040 |
Why?
|
| Moral Obligations | 1 | 2019 | 5 | 0.040 |
Why?
|
| Social Networking | 1 | 2019 | 23 | 0.040 |
Why?
|
| Germany | 1 | 2019 | 53 | 0.040 |
Why?
|
| Intraoperative Care | 1 | 2019 | 36 | 0.040 |
Why?
|
| Reference Standards | 1 | 2019 | 61 | 0.040 |
Why?
|
| Policy | 1 | 2019 | 48 | 0.040 |
Why?
|
| Confidentiality | 1 | 2019 | 53 | 0.040 |
Why?
|
| Total Disc Replacement | 1 | 2019 | 2 | 0.040 |
Why?
|
| Organ Size | 1 | 2019 | 165 | 0.040 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 173 | 0.040 |
Why?
|
| Syndrome | 1 | 2019 | 173 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 1 | 2019 | 46 | 0.040 |
Why?
|
| Cell Adhesion | 2 | 2009 | 209 | 0.040 |
Why?
|
| Bronchoscopy | 1 | 2019 | 78 | 0.040 |
Why?
|
| Cost Savings | 1 | 2019 | 56 | 0.040 |
Why?
|
| Budgets | 1 | 2018 | 8 | 0.040 |
Why?
|
| Marital Status | 1 | 2018 | 43 | 0.040 |
Why?
|
| Personnel Turnover | 1 | 2018 | 21 | 0.040 |
Why?
|
| Occupational Stress | 1 | 2018 | 16 | 0.040 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 143 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 629 | 0.030 |
Why?
|
| Operating Room Nursing | 1 | 2016 | 4 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2018 | 372 | 0.030 |
Why?
|
| Environment Design | 1 | 2016 | 26 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2011 | 1997 | 0.030 |
Why?
|
| Organizational Policy | 1 | 2016 | 54 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2017 | 137 | 0.030 |
Why?
|
| Communication Barriers | 1 | 2016 | 59 | 0.030 |
Why?
|
| Nursing Assessment | 1 | 2014 | 41 | 0.030 |
Why?
|
| Hospitalization | 1 | 2022 | 1301 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 186 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2013 | 255 | 0.030 |
Why?
|
| Age Distribution | 1 | 2013 | 262 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2011 | 2080 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 259 | 0.030 |
Why?
|
| Metabolism | 1 | 2011 | 14 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2011 | 33 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2016 | 450 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 99 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 21 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1094 | 0.020 |
Why?
|
| Biological Factors | 1 | 2011 | 23 | 0.020 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2011 | 38 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2011 | 70 | 0.020 |
Why?
|
| Vasodilation | 1 | 2011 | 38 | 0.020 |
Why?
|
| Potassium Channels | 1 | 2011 | 53 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2011 | 60 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 182 | 0.020 |
Why?
|
| Child | 1 | 2020 | 4328 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2011 | 111 | 0.020 |
Why?
|
| Phospholipids | 1 | 2011 | 79 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 168 | 0.020 |
Why?
|
| Chaperonin 60 | 1 | 2010 | 19 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2010 | 34 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 801 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2011 | 144 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2010 | 97 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 353 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 305 | 0.020 |
Why?
|
| Air Pollutants | 1 | 2011 | 84 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 187 | 0.020 |
Why?
|
| Leukocyte Rolling | 1 | 2009 | 3 | 0.020 |
Why?
|
| Cell Movement | 1 | 2011 | 425 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2009 | 37 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2010 | 76 | 0.020 |
Why?
|
| Microcirculation | 1 | 2009 | 51 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2009 | 135 | 0.020 |
Why?
|
| Particle Size | 1 | 2011 | 403 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2009 | 123 | 0.020 |
Why?
|
| Leukocytes | 1 | 2009 | 99 | 0.020 |
Why?
|
| Integrins | 1 | 2009 | 106 | 0.020 |
Why?
|
| Cell Communication | 1 | 2009 | 127 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2011 | 522 | 0.020 |
Why?
|
| Xanthine Oxidase | 1 | 2008 | 11 | 0.020 |
Why?
|
| Hyperuricemia | 1 | 2008 | 8 | 0.020 |
Why?
|
| Glucose | 1 | 2011 | 446 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2009 | 222 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 860 | 0.020 |
Why?
|
| Acinetobacter baumannii | 1 | 2008 | 5 | 0.020 |
Why?
|
| Imipenem | 1 | 2008 | 5 | 0.020 |
Why?
|
| Colistin | 1 | 2008 | 7 | 0.020 |
Why?
|
| Uric Acid | 1 | 2008 | 49 | 0.020 |
Why?
|
| Minocycline | 1 | 2008 | 25 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2009 | 249 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2009 | 204 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2008 | 54 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 638 | 0.020 |
Why?
|
| Medical Records | 1 | 2007 | 139 | 0.020 |
Why?
|
| Antioxidants | 1 | 2008 | 247 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 346 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2099 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 281 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2007 | 99 | 0.020 |
Why?
|
| Ischemia | 1 | 2007 | 193 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2009 | 647 | 0.010 |
Why?
|
| Biomarkers | 1 | 2009 | 1212 | 0.010 |
Why?
|
| Macrophages | 1 | 2009 | 1011 | 0.010 |
Why?
|
| Stroke | 1 | 2007 | 1143 | 0.010 |
Why?
|